Literature DB >> 16918765

5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle.

S Cellek1, A K John, R Thangiah, N B Dass, A K Bassil, E M Jarvie, O Lalude, S Vivekanandan, G J Sanger.   

Abstract

Previous studies have demonstrated mixed inhibitory and facilitatory effects of 5-hydroxytryptamine-4 (5-HT(4)) receptor agonists on electrical field stimulation (EFS)-induced responses in human isolated colon. Here we report three types of responses to EFS in human isolated colon circular muscle: monophasic cholinergic contraction during EFS, biphasic response (nitrergic relaxation during EFS followed by cholinergic contraction after termination of EFS) and triphasic response (cholinergic contraction followed by nitrergic relaxation during EFS and a tachykininergic contraction after EFS). The effects of two 5-HT(4) receptor agonists, prucalopride and tegaserod were then investigated on monophasic responses only. Each compound inhibited contractions during EFS in a concentration-dependent manner. In the presence of N(omega)-nitro-l-arginine methyl ester (l-NAME) however, prucalopride and tegaserod enhanced the contractions in a concentration-dependent manner. In strips where the tone was elevated with substance-P and treated with scopolamine, EFS-induced relaxations were enhanced by the two agonists. The above observed effects by the two agonists were abolished by 5-HT(4) receptor antagonist SB-204070. The two agonists did not alter the tone raised by substance-P in the presence of scopolamine and l-NAME and did not affect carbachol-induced contractions in the presence of tetrodotoxin. These results suggest that in the circular muscle of human colon, 5-HT(4) receptor agonists simultaneously facilitate the activity of neurones which release the inhibitory and excitatory neurotransmitters, nitric oxide and acetylcholine respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918765     DOI: 10.1111/j.1365-2982.2006.00810.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  19 in total

1.  Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders.

Authors:  Gareth J Sanger; Lin Chang; Chas Bountra; Lesley A Houghton
Journal:  Therap Adv Gastroenterol       Date:  2010-09       Impact factor: 4.409

2.  Selective desensitization of the 5-HT4 receptor-mediated response in pig atrium but not in stomach.

Authors:  J H De Maeyer; J A J Schuurkes; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2009-01-13       Impact factor: 8.739

3.  The novel, potent and highly selective 5-HT4 receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility.

Authors:  Eun Jeong Jeong; Soo Yong Chung; Han Na Hong; Se-Woong Oh; Jae Young Sim
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

Review 4.  Prokinetics in diabetic gastroparesis.

Authors:  Reza A Hejazi; Richard W McCallum; Irene Sarosiek
Journal:  Curr Gastroenterol Rep       Date:  2012-08

5.  Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro.

Authors:  M Aulí; E Martínez; D Gallego; A Opazo; F Espín; M Martí-Gallostra; M Jiménez; P Clavé
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

6.  5-HT4 receptor activation facilitates recovery from synaptic rundown and increases transmitter release from single varicosities of myenteric neurons.

Authors:  Jianhua Ren; Xiaoping Zhou; James J Galligan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-24       Impact factor: 4.052

7.  Prucalopride.

Authors:  James E Frampton
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 8.  Serotonin pharmacology in the gastrointestinal tract: a review.

Authors:  D T Beattie; J A M Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-09       Impact factor: 3.000

9.  Predominant mucosal expression of 5-HT₄(+h) receptor splice variants in pig stomach and colon.

Authors:  Evelien K V Priem; Joris H De Maeyer; Mado Vandewoestyne; Dieter Deforce; Romain A Lefebvre
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

10.  Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI, 1H and 31P MRS, and clinical and cognitive testing.

Authors:  Melissa Cambron; Tatjana Reynders; Jan Debruyne; Harmen Reyngoudt; Annemie Ribbens; Erik Achten; Guy Laureys
Journal:  J Neurol       Date:  2018-09-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.